Muls, V
37  results:
Search for persons X
?
1

P842 SARS-CoV-2 antibody titers analysis in immune mediated..:

Delaleeuwe, I ; Aoun, J ; Hoyois, A...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i968-i969 , 2023
 
?
2

OP28 A randomized placebo controlled clinical trial with 5-..:

Truyens, M ; Lobaton, T ; Peeters, A...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i029-i032 , 2022
 
?
3

P527 Investigating fatigue in vedolizumab-treated patients ..:

Louis, E ; Muls, V ; Bossuyt, P...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S503-S503 , 2021
 
?
4

P600 Vedolizumab dose optimisation: Findings from a Belgian..:

Louis, E ; Muls, V ; Bossuyt, P...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S501-S502 , 2020
 
?
5

P603 Persistence of vedolizumab maintenance therapy: Findin..:

Louis, E ; Muls, V ; Bossuyt, P...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S503-S504 , 2020
 
?
6

P131 Effectiveness and safety of vedolizumab maintenance th..:

Louis, E ; Muls, V ; Bossuyt, P...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S153-S154 , 2019
 
?
7

P723 Effectiveness and persistence of vedolizumab in patien..:

Reenaers, C ; Cremer, A ; Dewit, O...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S476-S477 , 2018
 
?
9

P550 Diagnosing and treating pediatric Crohn's disease pati..:

De Greef, E. ; Maus, B. ; Hoffman, I....
Journal of Crohn's and Colitis.  7 (2013)  - p. S231 , 2013
 
?
10

Profile of pediatric Crohn's disease in Belgium:

De Greef, E. ; Mahachie John, J.M. ; Hoffman, I....
Journal of Crohn's and Colitis.  7 (2013)  11 - p. e588-e598 , 2013
 
?
11

P320 Factors determining therapeutic strategy at diagnosis ..:

De Greef, E. ; Mahachie, J. ; Hofman, I....
Journal of Crohn's and Colitis.  6 (2012)  - p. S137 , 2012
 
?
12

Limitations of extensive TPMT genotyping in the management ..:

Dewit, O. ; Moreels, T. ; Baert, F....
Clinical Biochemistry.  44 (2011)  13 - p. 1062-1066 , 2011
 
?
14

Dyspeptic symptoms in the general population: a factor and ..:

piessevaux, h. ; de winter, b. ; louis, e....
Neurogastroenterology & Motility.  21 (2009)  4 - p. 378-388 , 2009
 
?
15

2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP..:

Macias, A. ; Torres, A. ; Montenegro, A....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 217 , 2007
 
1-15